baber/WOPTO huggingface dataset:
Patent CA-2723101-A1 (CA)
Title: Methode pour retirer des sols les contaminants inorganiques par une technique d'extraction physico-chimique
Inventor: LAMOTHE MARIE JOSEE
IPC: B09C1/02
Filed: 2009-05-04
Abstract: Une méthode pour décontaminer des sols d'un contaminant inorganique, comprenant: cribler les sols contaminés afin d'obtenir des fractions grossières et fines, tamiser les sols criblés afin d'en retenir les fractions grossières et, concurremment, laver les sols criblés afin d'obtenir un premier effluent comprenant le liquide de lavage et les fractions fines s'écoulant du tamis et comprenant des fines et des particules de dimensions supérieures à celles des fines, séparer les fines du premier effluent pour recirculer de l'eau propre et ainsi obtenir un second effluent, assurant l'alimentation du lavage, acheminer les fines contaminées et séparées du premier effluent vers une chambre chimique où une partie du premier effluent et une solution chimique sont ajoutées pour produire un troisième effluent (acide), celui-ci contenant des métaux dissous dans les fines qu'il faut séparer; le quatrième effluent comprend les fines et une précipitation de cet effluent est produite pour extraire les contaminants précipités, afin d'obtenir un cinquième effluent; par lequel le contaminant inorganique est extrait et on peut réutiliser le cinquième effluent pour une recirculation dans le procédé de traitement.
Patent CA-2723304-A1 (CA)
Inventor: GROS WIBKE
IPC: A61K8/34
Filed: 2009-02-17
Abstract: The object of the invention is an agent for bleaching keratinic fibers, characterized in that in a cosmetic carrier the same comprises firstly at least one cationic acyl pyridinium derivative of the formula (I), where R is a C1-C6-alkyl group, a C2-C6--alkenyl group, a C2-C6-hydroxy alkyl group, a C1-C6-alkoxy-C2-C6-alkyl group, a carboxy-C1-C6-alkyl group, an aryl-C1-C6-alkyl group, a C1-C6-dialkylamino-C2-C6-alkyl group, a heteroaryl-C1-C6-alkyl group, a 3-oxobutyl group, a 2-oxopropyl group, an aryl group, or a heteroaryl group, R' is a C1-C4-alkyl group, a C2-C6-hydroxy alkyl group, or a C1-C6-alkoxy-C2-C6-alkyl group, X- is a physiologically compatible anion, secondly at least one toxicologically safe co-bleaching activator and/or the physiologically compatible salt thereof, and thirdly hydrogen peroxide.
Patent CA-2724984-A1 (CA)
Title: Hollow porous membrane and process for producing the same
Inventor: TERAMACHI MASASHI
IPC: B01D69/10
Filed: 2009-05-21
Abstract: A hollow porous membrane with a reduced cost and excellent separation characteristic, water permeability, and mechanical strength and a process of producing the hollow porous membrane with an excellent adhesive property between a support and a porous membrane layer at a low cost are provided. The hollow porous membrane includes a porous membrane layer in which dense layers are disposed in the vicinities of an outer surface and an inner surface. In the process of producing the hollow porous membrane, membrane-forming dopes of a first membrane-forming dope and a second membrane-forming dope, which contain the material of the porous membrane layer and a solvent, are successively applied and stacked onto the outer circumferential surface of a hollow support and the applied membrane-forming dopes are simultaneously coagulated. In the process of producing the hollow porous membrane, a porous membrane layer is formed by applying a membrane-forming dope containing a material of the porous membrane layer and a solvent to the outer circumferential surface of the hollow support and coagulating the applied dope, and a hollow braid obtained by circularly knitting a yarn formed of multi-filaments is used as the support.
Patent CA-2725790-A1 (CA)
Inventor: BREEST JUERGEN
IPC: B29C41/38
Filed: 2009-07-06
Abstract: A method for manufacturing moulded flexible plastic skins (9, 24, 27, 34) differing in their shape from each other, each skin being moulded against a mould surface (2) of a mould (1), comprises the steps: - providing a mould surface (2) matching the shape of the skin to be moulded by using a first mould surface provided by the mould itself or by altering the first mould surface by placing one or more mould inserts covering only a part of the first mould surface onto said mould surface and thereby providing an alternative second mould surface, - applying a plastic compound to be brought to shape by the mould surface (2) provided, -bringing to shape the plastic compound applied to the mould surface (2), and -demoulding the moulded skin (9) from the effective mould surface (2). The at least one mould insert (7) used is flexible, whereas a mould insert (7) is arranged on the first mould surface in that the side surfaces of the insert adjoining its own mould surface abut against a wall of the first mould surface arranged angular to the adjacent mould surface, in particular an upstanding wall at least in those sections of the insert used for shaping the plastic compound. A mould arrangement for moulding flexible plastic skins (9) differing in their shape from each other, each skin moulded against a mould surface of a mould, the arrangement comprises a base mould with a first mould surface and one or more mould inserts to be arranged on the first mould surface and covering only a part of the first mould surface. The at least one mould insert is flexible nature and the first mould surface carries one or more walls arranged angular to the adjacent mould surface, in particular upstanding from its first mould surface and the mould inserts abut with their side surfaces adjoining their own mould surfaces against such wall at least in those sections of the insert used for shaping the plastic compound.
Patent CA-2726091-A1 (CA)
Title: System and methodology for development of a system architecture
Inventor: SENGUPTA ANIRBAN
IPC: G06F15/76
Filed: 2010-12-21
Abstract: Described embodiments relate to methods, systems and computer readable medium for developing a system architecture. Resources constraints are defined, where each resource constraint corresponds to a maximum number of a each kind of resources available to construct the system architecture. Constraint values for each of at least three optimization parameters are defined, which includes a final optimization parameter. A design space is defined as a plurality of vectors representing different combinations of a number of each kind of resource available to construct the system architecture. For each of the plurality of optimization parameters, a priority factor function is defined. A plurality of satisfying sets of vectors is determined for each of the optimization parameters except for the final optimization parameter. A set of vectors is determined based on an intersection of the plurality of satisfying sets of vectors for the optimization parameters. A vector is selected from the set of vectors based on the ordered list of vectors and the final optimization parameter, where the selected vector is for use in developing the system architecture.
Patent CA-2726744-A1 (CA)
Inventor: BEHAN NIALL
IPC: C08L83/10
Filed: 2009-06-19
Abstract: The present invention provides a viscoelastic biostable foam comprising a triblock copolymer of formula residue I. (see formula I)
Patent CA-2728742-A1 (CA)
Inventor: FIELD BRUCE F
IPC: C02F1/461
Filed: 2009-06-19
Abstract: A hand-held spray bottle (10, 400, 500, 500') is provided, which includes a liquid reservoir (12, 52, 88, 510), a liq-uid outlet (14, 74, 89, 508), an electrolysis cell (18, 50, 80, 406, 552, 708, 804), a power source (32, 402, 542) and a DC-to-DC  converter (1004). The electrolysis cell (18, 50, 80, 406, 552, 708, 804) is carried by the spray bottle (10, 400, 500, 500') and is fluidically coupled between the reservoir (12, 52, 88, 510) and the liquid outlet (14, 74, 89, 508). The power source (32, 402, 542) is carried by the spray bottle (10, 400, 500, 500') and has a voltage output.  The DC-to-DC converter (1004) is coupled between the voltage output and the electrolysis cell (18, 50, 80, 406, 552, 708, 804) and provides a stepped-up voltage, which is greater than the voltage output of the power source (32, 402, 542), to energize the electrolysis cell (18, 50, 80, 406, 552, 708, 804).
Patent CA-2729588-A1 (CA)
Inventor: POUTOT BENOIT
IPC: B65B21/24
Filed: 2009-07-02
Abstract: A packaging machine (10) comprising two or more packaging subsystems each capable of packaging articles (A) into a carton, wherein the packaging subsystems share a common source of articles (11) to be packaged and at least one transfer mechanism 5 (22) is provided for transferring articles (A) from the common source to any of the two or more packaging subsystems.
Patent CA-2730301-A1 (CA)
Inventor: RIVARD ALLEN J
IPC: B24B23/00
Filed: 2009-07-01
Abstract: The disclosure is directed to conversion assemblages adapted for use in converting a surface modifying apparatus having a supporting member, such as a pole sander, whereby the con-version assemblage includes a generally rigid body assembly including first and second major surfaces opposing each other, the first major surface is adapted for receiving the supporting member, and the second major surface is attach-able to a surface modifying member. The surface modifying apparatus may be an abrading apparatus. The disclosure is also directed to methods adapted for uti-lizing the conversion assemblages.
Patent CA-2732043-A1 (CA)
Title: Magnetic fluid seal with shunt element
Inventor: HELGELAND WALTER
IPC: F16J15/43
Filed: 2009-07-28
Abstract: A magneto-f luidic seal (10) includes a shaft (16), a pole piece, and a plurality of sealing fluid rings located between the shaft and the pole piece (30). The sealing fluid rings may be defined by the shaft and/or the pole piece and contain a ferromagnetic fluid. At least one channel (38,40) having a bottom is defined by either the shaft or the pole piece. A shunt (42) is located directly adjacent to the bottom of the channel. The thickness of the shunt is based on the energy differential (AE) in the plurality of sealing fluid rings as the fluid is displaced from one side of the sealing fluid rings to the other side of the sealing fluid rings.
Patent CA-2733177-A1 (CA)
Inventor: PETER OSTERMEIER
IPC: F16M11/00
Filed: 2011-03-03
Abstract: Add-on components (3) are to be fastened to a support part (5) with a simple technical set-up and without a need for tools, with a device (1) for fastening an add-on component (3) to a support part (5), comprising at least one movable holding element (16) that, when it is inserted into an opening (10) of the support part (5) due to the contact between the at least one holding element (16) and the support part (5), can be moved into an engagement position so as to be inserted into the opening (10), and that, after it has been inserted into the opening (10), can be moved into a catching position by means of a return movement of the at least one holding element (16) so that the at least one holding element (16) can catch behind at least one edge (9) of the support part (5) in order to create a positive connection between the at least one holding element (16) and the support part (5), and at least one means (12) for affixing the add-on component (3) to the device (1). This objective is achieved in that the at least one holding element (16) can be moved from the engagement position into the catching position by means of at least one elastic element (8).
Patent CA-2733187-A1 (CA)
Inventor: KOERSEN ELIZABETH
IPC: A63B71/00
Filed: 2011-03-03
Abstract: An open water training and safety device includes a flexible hollow cover having an internal cavity, and a flexible wall defining at least first and second compartments.  An amount of buoyant floatation material is mounted in the first compartment.  The buoyant material is sized to provide buoyancy for a swimmer supported by the device when floating in the water. The second compartment may be a pocket sized for carrying swimming accessories therein. The cover is closable so that the swimmer may selectively open and close the two compartments. Advantageously a hydration pack is mounted or mountable in one of the compartments. An elongate towing tether is mountable at a base end of the tether to the cover, for example by means of a harness which includes a pair of straps. The tether is adapted at a distal end thereof, distal from said base end, to be releasably mounted to the swimmer for towing said device behind the swimmer.
Patent CA-2733208-A1 (CA)
Inventor: BURKHARD WAGNER E
IPC: C08F10/00
Filed: 2009-08-06
Abstract: Methods of preparing a polymerization catalyst component is provided, in which a magnesium component, a Lewis acid solubilizing component, a titanium compound, optionally a transition metal compound different than the titanium compound, and typically an inert filler are combined in a slurrying agent and spray-dried to produce a catalyst precursor in the form of a substantially spherical and porous solid particle. The methods and catalysts of this disclosure can provide ethylene homopolymer and copolymer resins having a high molecular weight tail and a broadened molecular weight distribution as compared to more tradi-tional Ziegler-Natta catalysts.
Patent CA-2733845-A1 (CA)
Inventor: GINN RICHARD S
IPC: A61B17/03
Filed: 2003-04-30
Abstract: An apparatus for sealing a passage through tissue includes a threaded plug (12) detachably carried on a distal end of a delivery device (14). A  guide wire element (16) is receivable through the lumens extending through the plug (12) and delivery device (14) that includes expandable wings (50) adjacent its distal end, and markers adjacent its proximal end. During use, the guide wire element (16) is advanced through a passage through tissue into a blood vessel. The wings (50) on the distal end are expanded within the vessel, and the guide wire element (16) withdrawn until the wings contact a wall of the vessel. The plug (12) is moved into the passage over the guide wire element (16). The distal portion of the guide wire (16) may be secured to the plug (12), e.g., by compressing a collet (60) within the plug lumen that seals the lumen, and is severed from a proximal portion.
Patent CA-2736726-A1 (CA)
Inventor: NIGHTINGALE CHRISTOPHER GEORGE EDWARD
IPC: H01R12/00
Filed: 2009-09-11
Abstract: An electrical connection system (200) comprises a rail (202) and a plurality of electrically conducting posts (204) fixed to the rail (202). The rail (202) is in the form of a tube or rod provided with complimentary electrical connectors (208) and (210) at opposite ends. Each post (204) is coupled to a rail (202) by a short transverse link (205). A fitting (216) is provided at a free end (206) of each post (204) to facilitate mechanical and electrical connection with a through hole terminal. Pairs of rails (202) may be disposed side by side to form nominal positive and negative rails with the posts of the rails (202) interleaving each other and in mutual alignment.
Patent CA-2740423-A1 (CA)
Inventor: FARMER SEAN
IPC: A23L23/10
Filed: 2009-10-16
Abstract: The present application relates to probiotic grain-based compositions comprising lactic acid-producing bacteria selected from Bacillus coagulans. A claim is also directed to a dry mix for soup comprising Bacillus coagulans.
Patent CA-2742347-A1 (CA)
Title: Methods for gathering marine geophysical data
Inventor: HILLESUND OYVIND
IPC: G01V1/38
Filed: 2011-06-07
Abstract: In a first embodiment the invention comprises a method for gathering geophysical data, including towing geophysical data gathering equipment behind a survey vessel in a body of water, said equipment including an array of sensor streamers extending behind said vessel, and determining a geodetic location of a streamer steering reference point at a forward end of the sensor streamers and a reference direction. At least one sensor streamer included in said array of sensor streamers is laterally deflected in response to the determined geodetic location of said streamer steering reference point and the determined reference direction.
Patent CA-2742539-A1 (CA)
Inventor: BASTIAN JOLIE ANNE
IPC: A61P35/00
Filed: 2009-10-22
Abstract: The present invention provides novel 1,4-disubstituted phthalazine hedgehog pathway antagonists useful in the treatment of cancer.
Patent CA-2743499-A1 (CA)
Inventor: LIU NING
IPC: B01J43/00
Filed: 2009-11-12
Abstract: Phosphorylated peptides are extracted from digests of biological liquids and other peptide mixtures by fractiona-tion on ceramic hydroxyapatite. The ceramic hydroxyapatite is readily usable in a centrifuge, allowing for rapid fractionations of a large number of small volume samples, and accordingly high throughput.
Patent CA-2744977-A1 (CA)
Title: Detection d'anomalie dans un moteur d'aeronef
Inventor: LACAILLE JEROME
IPC: G05B17/02
Filed: 2009-11-26
Abstract: L'invention concerne un procédé et un système de détection d'anomalie dans un moteur d'aéronef (1), comportant :-des moyens (5) pour définir un modèle de comportement d'un moyen de contrôle (21) dudit moteur d'aéronef (1) selon une régression temporelle modélisant le comportement dudit moyen de contrôle (21) en fonction d'un jeu de données relatif audit moyen de contrôle comprenant des mesures des comportements passés et des mesures de commande et d'état dudit moyen de contrôle (21); -des moyens (5) pour recalculer de manière continue ledit modèle de comportement pour chaque nouveau jeu de données; et -des moyens (5) pour surveiller une évolution statistique dudit modèle de comportement pour détecter une anomalie de comportement dudit moyen de contrôle reflétant une anomalie de fonctionnement dudit moteur (1).
Patent CA-2745249-A1 (CA)
Inventor: TUERK HOLGER
IPC: C08F2/04
Filed: 2009-11-30
Abstract: The invention relates to a method for producing random radical copolymers, characterized by the following steps: a) dissolving by heating a) at least one olefinically unsaturated sulfonic acid of formula (I); wherein n is 0 to 10; X represents O or NR5; R1 represents hydrogen or methyl; R2, R3 independently represent hydrogen or C1 to C6 alkyl and R5 represents hydrogen, alkyl, aryl, alkylaryl, arylalkyl, alkoxyalkyl, aryloxyalkyl, alkoxyaryl, hydroxyalkyl, (di)alkylaminoalkyl, (di)alkylaminoaryl, (di)arylaminoalkyl, alkylarylaminoalkyl or alkylarylaminoaryl, wherein the aryl groups can be mono- or polysubstituted, the salts thereof or mixtures of acid and salts and b) at least two structurally distinct olefinically unsaturated monomers of formula (II), wherein Y represents O or NR7; R5 represents hydrogen or methyl; R6 represents alkyl, hydroxyalkyl, (di)alkylaminoalkyl or (di)alkylaminoaryl and R7 represents hydrogen, alkyl, aryl, alkylaryl, arylalkyl, alkoxyalkyl, aryloxyalkyl, alkoxyaryl, hydroxyalkyl, (di)alkylaminoalkyl, (di)alkylaminoaryl, (di)arylaminoalkyl, alkylarylaminoalkyl or alkylarylaminoaryl, and c) optionally one or more olefinically unsaturated monomers which can be structurally distinct from components (a) and (b), and at least one initiator, either (i) in a solvent mixture which contains water and a solvent having a boiling point below 140°C and being soluble in water, or (ii) in one or more pure alcohols, and polymerizing said mixture in solution, the copolymer formed also remaining dissolved. The copolymers obtainable according to the above method are suitable as formulation adjuvants in agrochemical active ingredient compositions.
Patent CA-2747170-A1 (CA)
Inventor: BAELL JONATHON BAYLDON
IPC: A01N43/00
Filed: 2009-12-17
Abstract: In one aspect, the present invention provides for a com-pound of Formula I; in which the variable X1a, X1b, X1c, X1d, Q, A, R1, B, L, E, and the subscripts m and n have the meanings as described herein. In another aspect, the present invention provides for pharmaceutical compo-sitions comprising compounds of Formula I as well as methods for using compounds of Formula I for the treatment of diseases and conditions (e.g., cancer, thrombocythemia, etc) characterized by the expression or over-ex-pression of Bcl-2 anti-apoptotic proteins, e.g., of anti-apoptotic Bcl-X L  proteins.
Patent CA-2748554-A1 (CA)
Inventor: JOHNSTON VICTOR J
IPC: C07C1/213
Filed: 2009-12-28
Abstract: This invention provides an integrated three step economical process for the production of vinyl acetate monomer (VAM) from acetic acid in the vapor phase. First, acetic acid is selectively hydrogenated over a hydrogenating catalyst composition to form ethyl acetate which is cracked to form ethylene and acetic acid in the second step and in a subsequent step so formed ethylene and acetic acid is reacted with molecular oxygen over a suitable catalyst to form VAM. In an embodiment of this invention reaction of acetic acid and hydrogen over platinum and copper supported on silica selectively produces ethyl acetate in a vapor phase at a temperature of about 250°C, which is cracked over a NAFION  catalyst to form ethylene and acetic acid at a temperature of about 185°C, which is mixed with molecular oxygen and reacted over a palladium/gold/potassium catalyst supported on titania to form VAM at a temperature of about 150°C to 170°C.
Patent CA-2751343-A1 (CA)
Inventor: PARK CHEOL-HYOUNG
IPC: C07D277/02
Filed: 2010-02-25
Abstract: Provided are a substituted azole derivative and pharmaceutically acceptable salts thereof, a pharmaceutical composition including an effective amount of the derivative, and a method for treating Parkinson's disease in a mammal including administering an effective amount of the compound to the mammal. The azole derivative of the following Formula (I) and pharmaceutically useful salts thereof have an efficacy against Parkinson's disease from inhibitory effects of the activity of MAO-B.
Patent CA-2752157-A1 (CA)
Inventor: GOAD MARY ELIZABETH PECQUET
IPC: A61K38/18
Filed: 2010-02-12
Abstract: The present invention is directed to methods and compositions for accomplishing systemic delivery of minimally--soluble bioactive agents such as, but not limited to, proteins of the TGF-.beta.  superfamily via a peripheral mode of administration.  According to the invention, an exemplary bioactive agent is BMP-7. The invention further provides for minimally-invasive systemic treatment of skeletal disorders such as osteoporosis as well as minimally-invasive systemic treatment of injured or diseased non-mineralized tissues and organs such kidneys. Practice of the invention eliminates adverse side effects at the peripheral site of intravenous administration of the bioactive agent.
Patent CA-2754393-A1 (CA)
Title: Evaporation a travers une membrane pour la generation de produits therapeutiques proteiques tres concentres
Inventor: BOLTON GLEN REED
IPC: A61K39/395
Filed: 2010-03-24
Abstract: La présente invention concerne des procédés de génération de solutions protéiques très concentrées, par exemple, une solution d'anticorps, une solution protéique thérapeutique, etc. Les procédés de l'invention comprennent l'évaporation à travers une membrane, par exemple l'évaporation d'un solvant sans protéine de la solution protéique, qui entraîne la concentration de la protéine. Les procédés de la présente invention résultent en des concentrations de la solution protéique jamais obtenues jusqu'à présent à l'aide des procédés d'ultrafiltration classiques, par exemple, des concentrations de la solution protéique supérieures à environ 260 grammes de protéine par litre de solution.
Patent CA-2756842-A1 (CA)
Inventor: RUSCHULTE JOERG
IPC: B60C27/18
Filed: 2010-02-08
Abstract: The invention relates to a woven textile web material having an upper fabric layer (O) and a lower fabric layer (U), comprising warp threads (K) and first and second weft threads, and comprising carrier filaments (FF) and enwinding filaments (UF) encompassing the same as second weft threads, characterized in that the carrier filaments (FF) are integrated in the textile web material such that they appear at the surface of the upper fabric layer (O) in first width areas (I) substantially parallel to the warp thread direction, and do not appear at the surface of the upper fabric layer (O) in second width areas (II) substantially parallel to the warp thread direction (O).